SCH 50911

Known as: SCH-50911 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2018
024619952018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Different effects of moderate to high doses of gamma-hydroxybutyric acid, including sedation/hypnosis, have been found to be… (More)
Is this relevant?
2002
2002
The present study investigated the effect of the GABA(B) receptor antagonist, SCH 50911 [(2S)(+)-5,5-dimethyl-2-morpholineacetic… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
The striatum is a crucial site of action for the motor effects of cannabinoids (CBs). However, the electrophysiological… (More)
Is this relevant?
2001
2001
In many areas of the nervous system, excitatory and inhibitory synapses are reconfigured during early development. We have… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2001
2001
The present study was aimed at identifying the receptor systems involved in the mediation of the sedative/hypnotic effect of… (More)
Is this relevant?
2000
2000
The gamma-aminobutyric acid type A (GABAA) receptor agonist muscimol is widely used as a tool for reducing neuronal activities… (More)
Is this relevant?
1999
1999
Previous studies have shown that systemic as well as local administration of the GABAB-receptor agonist baclofen is associated… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1999
1999
Kainate (KA) receptor activation depresses stimulus-evoked gamma-aminobutyric acid (GABA-mediated) synaptic transmission onto CA1… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
1995
1995
Experiments were conducted to characterize the pharmacology of SCH 50911 ((+)-5,5-dimethyl-2-morpholineacetic acid hydrochloride… (More)
Is this relevant?
1995
1995
Recent studies have shown that gamma-aminobutyric acidB (GABAB) receptor antagonists suppress absence seizures in animal models… (More)
Is this relevant?